| August 28 ,2008 |
Astellas Day (Information Meeting on Astellas Global Marketing Activities)
|
| August 28 ,2008 |
Annual Report 2008
|
| August 22 ,2008 |
Notice of Completion of Acquisition of Treasury Stock
(PDF 24KB) |
| August 15 ,2008 |
Notice of the Result of Acquisition of Treasury Stock through ToSTNeT-3
(PDF 28KB) |
| August 14 ,2008 |
Notice of Acquisition of Treasury Stock through ToSTNeT-3
(PDF 25KB) |
| August 13 ,2008 |
Cardiome and Astellas Announce Receipt of FDA Approvable Letter for KYNAPID
(PDF 89KB) |
| August 1 ,2008 |
Business resurlts for 1Q/FY2008
|
| August 1 ,2008 |
Astellas Announces Acquisition of Treasury Stock
(PDF 45KB) |
| August 1 ,2008 |
Astellas Launches the Candin Antifungal Agent Mycamine® in the UK
(PDF 94KB) |
| July 22 ,2008 |
ASTELLAS AND BOEHRINGER FILED LAWSUIT AGAINST FLOMAX® GENERIC FOR PATENT INFRINGEMENT IN THE US
(PDF 28KB) |
| July 17 ,2008 |
Astellas Receives a Japanese Marketing Approval for Irribow®
(PDF 75KB) |
| July 17 ,2008 |
Astellas Receives a Japanese Marketing Approval for the Immunosuppressant Graceptor®
(PDF 23KB) |
| June 25 ,2008 |
ASTELLAS LAUNCHES LEXISCAN(tm) (REGADENOSON) INJECTION FOR USE AS A PHARMACOLOGIC STRESS AGENT IN RADIONUCLIDE MYOCARDIAL PERFUSION IMAGING (MPI)
(PDF 27KB) |
| June 24 ,2008 |
New strength added to fluvoxamine maleate, 75mg tablets launched
(PDF 30KB) |
| June 23 ,2008 |
Notice of Completion of Acquisition of Treasury Shares
(PDF 24KB) |
| June 23 ,2008 |
Submit an sNDA for the immunosuppressant Prograf® for Ulcerative Colitis in Japan
(PDF 15KB) |
| June 20 ,2008 |
Astellas to Support Relief Efforts following Iwate-Miyagi Inland Earthquake
(PDF 29KB) |
| May 16 ,2008 |
Astellas to Support Relief Efforts following China Earthquake
(PDF 29KB) |
| May 13 ,2008 |
Announcement of FY2007 results |
| May 13 ,2008 |
Astellas Announces Acquisition of Treasury Stocks
(PDF 45KB) |
| May 13 ,2008 |
Astellas Announces Cancellation of Treasury Stocks
(PDF 31KB) |
| May 13 ,2008 |
Issuance of Stock Acquisition Rights for Stock Option Scheme as Stock-Linked Compensation Plan
(PDF 55KB) |
| May 7 ,2008 |
Mycamine® Has Now Been Approved in Europe
(PDF 94KB) |
| May 7 ,2008 |
Astellas Receives an Approvable Letter for an Immunosuppressant FK506 Modified Release Formulation in the U.S.
(PDF 46KB) |
| April 25 ,2008 |
Astellas and CoMentis Sign Agreement to Collaborate on the Research, Development
and Commercialization of Beta-Secretase Inhibitors
(PDF 32KB) |
| April 24 ,2008 |
Change of Representative Directors
(PDF 31KB) |
| April 11 ,2008 |
CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM)
(regadenoson) Injection
(PDF 23KB) |
| April 2 ,2008 |
The FDA Accepts the Complete Response for Clinical Holds of FG-2216*/FG-4592 for the Treatment of Anemia
(PDF 34KB) |
| April 1 ,2008 |
IR website renewed.
|
| March 14 ,2008 |
Astellas Receives an Approvable Letter for Their Immunosuppressant FK506 Modified Release Formulation in the U.S. (PDF 48KB) |
| March 10 ,2008 |
Conclusion of Co-Development and Co-Marketing Agreement on a Functional Dyspepsia Agent Z-338/YM443 in Japan with Zeria
(PDF 28KB) |
| March 10 ,2008 |
The abstract of the result of Phase IIa study in EU for the beta 3 adrenoceptor agonist YM178 is available on the website of the 23rd European Association of Urology (EAU) annual congress held during March 26 to 29, 2008.
|
| March 5 ,2008 |
Astellas Reaches Settlement Agreement with Taiyo on the Oral Cephalosporin
Antibiotic Cefzon® Litigations
(PDF 30KB) |
| March 4 ,2008 |
Astellas Announces Global Management System and Establishes Global Development
Functional Headquarters
(PDF 53KB) |
| March 4 ,2008 |
Theravance, Inc. issued press release with regard to FDA cancellation of Advisory Committee meeting for the injectable antibiotic telavancin.
|
